The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market size has grown strongly in recent years. It will grow from $1.95 billion in 2025 to $2.09 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising coronary artery disease prevalence, aging population, advancements in interventional cardiology, improved diagnostic imaging, hospital catheterization expansion.
The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market size is expected to see strong growth in the next few years. It will grow to $2.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growth in cardiovascular interventions, emerging market healthcare investments, innovation in catheter materials, increasing clinical expertise, adoption of precision cardiology. Major trends in the forecast period include increasing preference for minimally invasive procedures, growing use of high-pressure non-compliant catheters, demand for improved balloon material durability, expansion of cath lab infrastructure, focus on procedural success rate improvement.
The increase in cardiovascular diseases is increasingly supporting the expansion of the percutaneous transluminal coronary angioplasty dilation catheters market going forward. Cardiovascular diseases are rising due to lifestyle-related factors such as poor dietary habits, physical inactivity, elevated stress levels, and aging populations. Percutaneous transluminal coronary angioplasty dilation catheters are widely used to treat cardiovascular conditions by opening narrowed or blocked coronary arteries, thereby restoring adequate blood flow to the heart. For example, in June 2024, according to the American Heart Association, projections indicate that 45 million adults in the United States may have some form of cardiovascular disease by 2050, up from 28 million in 2020, with significant increases expected in hypertension and obesity rates. Consequently, the growing burden of cardiovascular diseases is reinforcing growth in the PTCA dilation catheters market.
Leading companies in the percutaneous transluminal coronary angioplasty dilation catheters market are focusing on developing advanced products such as dilation catheters with twin-wall technology to enhance balloon strength and enable effective artery dilation. Twin-wall technology incorporates two concentric layers to improve catheter strength, flexibility, and durability. For example, in February 2023, SIS Medical AG, a Switzerland-based medical device company, launched the OPN NC PTCA dilation catheter with twin-wall technology in the US. The catheter offers high pressure resistance with a rated burst pressure of 35 atm and low compliance, making it suitable for post-dilatation of under-expanded stents and effective treatment of complex coronary lesions without over-dilation.
In June 2024, Boston Scientific Corporation, a US-based medical device manufacturing company, acquired Silk Road Medical Inc. for an undisclosed amount. This acquisition strengthens Boston Scientific’s presence in the vascular and endovascular markets, particularly in the treatment of carotid artery disease. Silk Road Medical Inc. is a US-based manufacturer of medical equipment.
Major companies operating in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, GADA S.p.A., Invamed Group.
North America was the largest region in the percutaneous transluminal coronary angioplasty dilation catheters market in 2025. The regions covered in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported catheter materials such as polyurethane, nylon, and specialty polymers, raising production expenses for PTCA dilation catheter manufacturers. These impacts are most pronounced in high pressure non compliant and specialized semi compliant catheter segments, particularly in Asia-Pacific and Europe where many components are sourced globally. The resulting cost pressures have affected pricing for hospitals and medical research institutes, potentially slowing procurement cycles. However, tariffs are also encouraging regional sourcing of raw materials and local catheter assembly, improving supply chain resilience and supporting long term manufacturing stability.
The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market research report is one of a series of new reports that provides percutaneous transluminal coronary angioplasty (ptca) dilation catheters market statistics, including percutaneous transluminal coronary angioplasty (ptca) dilation catheters industry global market size, regional shares, competitors with a percutaneous transluminal coronary angioplasty (ptca) dilation catheters market share, detailed percutaneous transluminal coronary angioplasty (ptca) dilation catheters market segments, market trends and opportunities, and any further data you may need to thrive in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters industry. This percutaneous transluminal coronary angioplasty (ptca) dilation catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Percutaneous transluminal coronary angioplasty (PTCA) dilation catheters are medical tools used to open narrowed or blocked coronary arteries. They work by inserting a catheter with a small balloon at the tip into the artery and inflating it to widen the vessel and enhance blood flow, helping restore normal circulation to the heart through a minimally invasive procedure.
The primary types of percutaneous transluminal coronary angioplasty (PTCA) dilation catheters include semi-compliant and non-compliant variants. Semi-compliant PTCA dilation catheters are engineered to expand under applied pressure while retaining a controlled degree of flexibility, enabling them to conform to vessel anatomy and provide effective dilation with reduced risk of vessel injury. These catheters are manufactured using materials such as polyurethane, nylon, and others and are used in applications across hospitals, medical research institutions, and others.
The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market consists of sales of balloon catheters, drug-eluting balloon catheters, scoring balloon catheters, and cutting balloon catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market size is expected to see strong growth in the next few years. It will grow to $2.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growth in cardiovascular interventions, emerging market healthcare investments, innovation in catheter materials, increasing clinical expertise, adoption of precision cardiology. Major trends in the forecast period include increasing preference for minimally invasive procedures, growing use of high-pressure non-compliant catheters, demand for improved balloon material durability, expansion of cath lab infrastructure, focus on procedural success rate improvement.
The increase in cardiovascular diseases is increasingly supporting the expansion of the percutaneous transluminal coronary angioplasty dilation catheters market going forward. Cardiovascular diseases are rising due to lifestyle-related factors such as poor dietary habits, physical inactivity, elevated stress levels, and aging populations. Percutaneous transluminal coronary angioplasty dilation catheters are widely used to treat cardiovascular conditions by opening narrowed or blocked coronary arteries, thereby restoring adequate blood flow to the heart. For example, in June 2024, according to the American Heart Association, projections indicate that 45 million adults in the United States may have some form of cardiovascular disease by 2050, up from 28 million in 2020, with significant increases expected in hypertension and obesity rates. Consequently, the growing burden of cardiovascular diseases is reinforcing growth in the PTCA dilation catheters market.
Leading companies in the percutaneous transluminal coronary angioplasty dilation catheters market are focusing on developing advanced products such as dilation catheters with twin-wall technology to enhance balloon strength and enable effective artery dilation. Twin-wall technology incorporates two concentric layers to improve catheter strength, flexibility, and durability. For example, in February 2023, SIS Medical AG, a Switzerland-based medical device company, launched the OPN NC PTCA dilation catheter with twin-wall technology in the US. The catheter offers high pressure resistance with a rated burst pressure of 35 atm and low compliance, making it suitable for post-dilatation of under-expanded stents and effective treatment of complex coronary lesions without over-dilation.
In June 2024, Boston Scientific Corporation, a US-based medical device manufacturing company, acquired Silk Road Medical Inc. for an undisclosed amount. This acquisition strengthens Boston Scientific’s presence in the vascular and endovascular markets, particularly in the treatment of carotid artery disease. Silk Road Medical Inc. is a US-based manufacturer of medical equipment.
Major companies operating in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, GADA S.p.A., Invamed Group.
North America was the largest region in the percutaneous transluminal coronary angioplasty dilation catheters market in 2025. The regions covered in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported catheter materials such as polyurethane, nylon, and specialty polymers, raising production expenses for PTCA dilation catheter manufacturers. These impacts are most pronounced in high pressure non compliant and specialized semi compliant catheter segments, particularly in Asia-Pacific and Europe where many components are sourced globally. The resulting cost pressures have affected pricing for hospitals and medical research institutes, potentially slowing procurement cycles. However, tariffs are also encouraging regional sourcing of raw materials and local catheter assembly, improving supply chain resilience and supporting long term manufacturing stability.
The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market research report is one of a series of new reports that provides percutaneous transluminal coronary angioplasty (ptca) dilation catheters market statistics, including percutaneous transluminal coronary angioplasty (ptca) dilation catheters industry global market size, regional shares, competitors with a percutaneous transluminal coronary angioplasty (ptca) dilation catheters market share, detailed percutaneous transluminal coronary angioplasty (ptca) dilation catheters market segments, market trends and opportunities, and any further data you may need to thrive in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters industry. This percutaneous transluminal coronary angioplasty (ptca) dilation catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Percutaneous transluminal coronary angioplasty (PTCA) dilation catheters are medical tools used to open narrowed or blocked coronary arteries. They work by inserting a catheter with a small balloon at the tip into the artery and inflating it to widen the vessel and enhance blood flow, helping restore normal circulation to the heart through a minimally invasive procedure.
The primary types of percutaneous transluminal coronary angioplasty (PTCA) dilation catheters include semi-compliant and non-compliant variants. Semi-compliant PTCA dilation catheters are engineered to expand under applied pressure while retaining a controlled degree of flexibility, enabling them to conform to vessel anatomy and provide effective dilation with reduced risk of vessel injury. These catheters are manufactured using materials such as polyurethane, nylon, and others and are used in applications across hospitals, medical research institutions, and others.
The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market consists of sales of balloon catheters, drug-eluting balloon catheters, scoring balloon catheters, and cutting balloon catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Characteristics
3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Supply Chain Analysis
4. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Trends and Strategies
5. Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Analysis of End Use Industries
7. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Total Addressable Market (TAM) Analysis for the Market
9. Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Segmentation
10. Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Regional and Country Analysis
11. Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
12. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
13. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
14. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
15. Australia Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
16. Indonesia Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
17. South Korea Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
18. Taiwan Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
19. South East Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
20. Western Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
21. UK Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
22. Germany Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
23. France Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
24. Italy Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
25. Spain Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
26. Eastern Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
27. Russia Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
28. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
29. USA Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
30. Canada Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
31. South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
32. Brazil Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
33. Middle East Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
34. Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market
36. Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Competitive Landscape and Company Profiles
37. Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Other Major and Innovative Companies
40. Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses percutaneous transluminal coronary angioplasty (ptca) dilation catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for percutaneous transluminal coronary angioplasty (ptca) dilation catheters? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Semi-Compliant Type; Non-Compliant Type2) By Material Type: Polyurethane; Nylon; Other Material Types
3) By Application: Hospitals; Medical Research Institute; Other Applications
Subsegments:
1) By Semi-Compliant Type: Standard Semi-Compliant Catheters; Specialized Semi-Compliant Catheters2) By Non-Compliant Type: Standard Non-Compliant Catheters; High-Pressure Non-Compliant Catheters
Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic plc; Koninklijke Philips N.V.; Becton Dickinson and Company; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; Teleflex Incorporated; Lepu Medical Technology (Beijing) Co Ltd.; Merit Medical Systems Inc.; Cordis Corporation; MicroPort Scientific Corporation; Biosensors International Group Ltd.; Alvimedica Medical Technologies; BrosMed Medical Co Ltd.; iVascular SLU; Hexacath; Translumina Therapeutics LLP; Eurocor Tech GmbH; GADA S.p.A.; Invamed Group
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters market report include:- Cardinal Health Inc.
- Abbott Laboratories
- Medtronic plc
- Koninklijke Philips N.V.
- Becton Dickinson and Company
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Teleflex Incorporated
- Lepu Medical Technology (Beijing) Co Ltd.
- Merit Medical Systems Inc.
- Cordis Corporation
- MicroPort Scientific Corporation
- Biosensors International Group Ltd.
- Alvimedica Medical Technologies
- BrosMed Medical Co Ltd.
- iVascular SLU
- Hexacath
- Translumina Therapeutics LLP
- Eurocor Tech GmbH
- GADA S.p.A.
- Invamed Group
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.09 Billion |
| Forecasted Market Value ( USD | $ 2.68 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
